Energy Equipment and Services

Core Laboratories Luxembourg SA

Core Laboratories Luxembourg SA released FY2026 Q1 earnings on April 29 After-Market EST, actual revenue USD 121.8 M (forecast USD 124.93 M), actual EPS USD -0.02 (forecast USD 0.06)

Core Laboratories Luxembourg SA to release FY2026 Q1 earnings on April 29 After-Market EST, forecast revenue USD 124.93 M, EPS USD 0.06

Core Laboratories Luxembourg SA released FY2025 Q4 earnings on February 4 After-Market (EST), actual revenue USD 138.26 M (forecast USD 130.4 M), actual EPS USD 0.15 (forecast USD 0.2)

Core Laboratories Luxembourg SA released FY2025 earnings on February 4 After-Market EST, actual revenue USD 526.52 M (forecast USD 518.68 M), actual EPS USD 0.63 (forecast USD 0.72)

Core Laboratories Luxembourg SA to Release FY2025 Q4 Earnings on February 4, 2026 After-Market EST, Forecast Revenue USD 130.4 M, EPS USD 0.2

Core Laboratories Luxembourg SA released FY2025 Q3 earnings on October 22 After-Market EST, forecast revenue USD 131.3 M, forecast EPS USD 0.2

Core Laboratories Luxembourg SA released FY2025 9-month earnings on October 22 After-Market EST, actual revenue USD 388.27 M, actual EPS USD 0.5167

Core Laboratories Luxembourg SA to release FY2025 Q3 earnings on October 22 After-Market EST, forecast revenue USD 130.73 M, EPS USD 0.1973

Core Laboratories Luxembourg SA released FY2025 Q2 earnings on July 23 After-Market EST, actual revenue USD 130.16 M (forecast USD 128.69 M), actual EPS USD 0.22 (forecast USD 0.179)

Core Laboratories Luxembourg SA released FY2025 Semi-Annual earnings on July 23 After-Market EST, actual revenue USD 253.74 M, actual EPS USD 0.22

Core Laboratories Luxembourg SA to Release FY2025 Q2 Earnings on July 23 After-Market EST, Forecast Revenue USD 129.19 M, EPS USD 0.179

Core Laboratories Luxembourg SA released FY2025 Q1 earnings on April 23 After-Market EST, actual revenue USD 123.59 M (forecast USD 124.76 M), actual EPS USD -0.0032 (forecast USD 0.1329)

Core Laboratories Luxembourg SA to Release FY2025 Q1 Earnings on April 23 After-Market EST, Forecast Revenue USD 124.76 M, EPS USD 0.1329

Core Laboratories Luxembourg SA released FY2024 Q4 earnings on January 29 After-Market (EST), actual revenue $129.24M (forecast $133.35M), actual EPS $0.1549 (forecast $0.2088)

Core Laboratories Luxembourg SA to Release FY2024 Q4 Earnings on January 29, 2025, After-Market EST; Forecast Revenue 133.35 M USD, EPS 0.2018 USD

Core Laboratories Luxembourg SA released FY2024 annual earnings on January 15 After-Market (EST), actual revenue $523.85M (forecast $527.83M), actual EPS $0.66 (forecast $0.7728)

Core Laboratories Inc. to Release Q3 2024 Earnings After-Market on Oct 23, 2024

Core Laboratories Inc. released Q3 2024 earnings on October 23, 2024, with revenue of 394.61M USD and EPS of 0.5087 USD

Core Laboratories Luxembourg SA released FY2024 Q2 earnings on July 24 After-Market (EST): Actual Revenue $130.577M (Forecast $132.84M), Actual EPS $0.19 (Forecast $0.2306)

Core Laboratories stock rating downgraded to sell

InMed Pharmaceuticals

AMPLITECH GROUP INC. USD0.001 S/R 20/11/26 SER B

Amesite

CN Energy

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

NextNRG

Meiwu Tech

Generation Income Properties

MetaVia

OceanPal

BORR

Borr Drilling and Core Laboratories shares surged by 4.9% and 4.4% respectively, driven by rising crude oil prices above $100 a barrel amid geopolitical tensions. The Energy Select Sector SPDR Fund (XLE) also gained 2.4%. Borr Drilling's stock has increased 65.8% this year, reaching a new 52-week high of $6.62. Investors are advised to consider the volatility and potential opportunities in the current market.

Stock Story

Borr Drilling

Pro Ultr Bloomberg Crude Oil

VanEck Oil Services ETF

SPDR Energy Select

ISHRS S&P Glb Engy

iShares US Oil Equip & Svcs

iShares US Oil & Gas Expl & Prod

VG Energy

SPDR O&G Equip

Us Brent Oil

VanEck Oil Refiners ETF

SPDR O&G Ex & Prd

United States Oil Fund LP

Exxon Mobil

Chevron

ConocoPhillips

Amazon

Alphabet

Alphabet - C

Paypal

Meta Platforms

Borr Drilling and Core Laboratories Shares Are Soaring, What You Need To Know

Core Laboratories Inc. held its Annual Meeting of Shareholders on May 12, 2026, where shareholders re-elected directors Harvey Klingensmith and Curtis Anastasio, ratified KPMG LLP as the independent auditor for 2026, and supported the executive compensation philosophy. The latest analyst rating for CLB stock is a Sell with a price target of $11.50. Spark's AI Analyst rates CLB as Neutral, citing weak technicals and revenue decline, but improved leverage and solid margins. Core Laboratories provides services to the upstream energy industry, focusing on optimizing reservoir performance.

Tip Ranks

Core Laboratories Shareholders Back Directors, Auditor and Pay

NCSM

The energy sector presents buying opportunities for undervalued stocks as the RSI indicates oversold levels. NCS Multistage, Core Laboratories, and Transportadora de Gas del Sur SA are highlighted, with RSI values near or below 30. NCS Multistage's stock fell 36% recently, Core Laboratories dropped 20%, and Transportadora de Gas del Sur SA declined 15%. Each company reported disappointing quarterly results, contributing to their stock price declines. Investors may consider these stocks for potential rebounds in Q2.

benzinga_article

Transportadora De Gas

NCS Multistage

Top 3 Energy Stocks That May Jump In Q2

CS精准医

003008

CS Analytical Laboratory has announced a major expansion of its Clifton, New Jersey facility, doubling its laboratory space to meet increasing client demands in the pharmaceutical, biotechnology, and medical device sectors. This expansion will enhance their capacity for innovative testing services, including raw materials testing and microbiological services, while also creating high-quality jobs. The facility is the only cGMP, FDA-registered contract laboratory dedicated to container testing, reinforcing its leadership in the industry.

prnewswire

Geratherm Medical AG

KETOP

03:50 ETCS Analytical Announces Major Laboratory Expansion

Core Laboratories Inc (CLB) shares fell below their 200-day moving average of $15.08, trading as low as $14.20, marking a decline of about 15.4% on the day. The stock's 52-week range is between $9.72 and $20.36, with the last trade at $14.72.

nasdaq

Nasdaq

Core Laboratories (CLB) Shares Cross Below 200 DMA

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Core Lab (CLB) Q1 2026 Earnings Transcript

Core Laboratories shares are trading lower after the company reported worse-than-expected Q1 financial results.

Core Laboratories (NYSE:CLB) has updated its Q2 2026 earnings guidance, projecting EPS between 0.060-0.120, below the consensus estimate of 0.150. Revenue guidance is set at $123.0 million-$131.0 million, compared to the consensus of $127.8 million. The stock recently rose 2.6% to $17.21, with an average rating of "Hold" from analysts. The company also announced a quarterly dividend of $0.01 per share. Institutional investors hold 97.81% of the stock, reflecting strong institutional interest in the company.

Core Laboratories Luxembourg SA(CLB.US)